Who makes Maalox Plus extra?

Maalox Plus extra is developed by Helen Reynolds.

What development phase is Maalox Plus extra in?

Maalox Plus extra is in Phase 1.

Last reviewed 2026-04-20 · How we verify

Maalox Plus extra

Helen Reynolds · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	Maalox Plus extra
Sponsor	Helen Reynolds
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

The Effects of Moviprep With Simethicone on Colonic Bubbles (NA)
Effect of Antacids on the Pharmacokinetics of Raltegravir (PHASE1)
The Effect of Antacids and Multivitamins on Raltegravir (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Maalox Plus extra CI brief — competitive landscape report
Maalox Plus extra updates RSS · CI watch RSS
Helen Reynolds portfolio CI